» Articles » PMID: 20053802

Abrupt Regression of a Meningioma After Discontinuation of Cyproterone Treatment

Overview
Specialty Neurology
Date 2010 Jan 8
PMID 20053802
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

The multiplicity of meningiomas or abrupt lesion growth in patients treated with cyproterone acetate suggests that this progestative treatment may promote lesion growth. We report the rapid regression of an incidental meningioma after discontinuation of a 10-year cyproterone acetate treatment. This unique observation suggests that conservative management of meningiomas may be the best option among users of high doses of cyproterone acetate, given that spontaneous regression may occur after hormonal treatment discontinuation.

Citing Articles

Petroclival meningioma regression after combined oestrogen and nomegestrol acetate interruption.

Lebeau J, Deprez L, Pintiaux A, Reuter G BMJ Case Rep. 2025; 18(1.

PMID: 39828291 PMC: 11751604. DOI: 10.1136/bcr-2024-263529.


Recommendations on the management of meningioma and sex hormone therapy: The results of a collaborative effort between neurosurgical, endocrine and gynecological societies.

Reuter G, Potorac I, De Herdt C, Ameryckx L, Brichant G, Froelich S Brain Spine. 2025; 5():104154.

PMID: 39802864 PMC: 11721832. DOI: 10.1016/j.bas.2024.104154.


Regression of multiple intracranial meningiomas after cessation of long-term synthetic progesterone (megestrol) medication: case report and autopsy.

AlDoheyan T, Del Bigio M Free Neuropathol. 2024; 5:27.

PMID: 39473896 PMC: 11519963. DOI: 10.17879/freeneuropathology-2024-5813.


Spontaneous regression of a petroclival meningioma: illustrative case.

Noda R, Kawashima M, Akabane A, Inoue T J Neurosurg Case Lessons. 2024; 8(15).

PMID: 39378522 PMC: 11465344. DOI: 10.3171/CASE24416.


Regression of all untreated lesions in multifocal low-grade meningioma following fractionated stereotactic radiotherapy-abscopal effect or spontaneous regression? : Case report and review of the literature.

Pinkawa M, Bostrom J, Temming S, Schafer A, Kovacs A, Bostrom A Strahlenther Onkol. 2024; 201(2):191-196.

PMID: 38871938 DOI: 10.1007/s00066-024-02248-0.


References
1.
Shimizu J, Matsumoto M, Yamazaki E, Yasue M . Spontaneous regression of an asymptomatic meningioma associated with discontinuation of progesterone agonist administration. Neurol Med Chir (Tokyo). 2008; 48(5):227-30. DOI: 10.2176/nmc.48.227. View

2.
Moss J, DeCastro R, Patronas N, Taveira-DaSilva A . Meningiomas in lymphangioleiomyomatosis. JAMA. 2001; 286(15):1879-81. DOI: 10.1001/jama.286.15.1879. View

3.
Wigertz A, Lonn S, Mathiesen T, Ahlbom A, Hall P, Feychting M . Risk of brain tumors associated with exposure to exogenous female sex hormones. Am J Epidemiol. 2006; 164(7):629-36. DOI: 10.1093/aje/kwj254. View

4.
Matsuda Y, Kawamoto K, Kiya K, Kurisu K, Sugiyama K, Uozumi T . Antitumor effects of antiprogesterones on human meningioma cells in vitro and in vivo. J Neurosurg. 1994; 80(3):527-34. DOI: 10.3171/jns.1994.80.3.0527. View

5.
de Almeida J, Petteys R, Sciubba D, Gallia G, Brem H . Regression of intracranial meningioma following intratumoral hemorrhage. J Clin Neurosci. 2009; 16(9):1246-9. DOI: 10.1016/j.jocn.2008.11.017. View